NCT00007345 - Depsipeptide to Treat Patients With Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma | Biotech Hunter

Enrollment

131

Participants

Timeline

Start Date

March 8, 2001

Primary Completion Date

January 26, 2015

Study Completion Date

July 27, 2015

Conditions

Cutaneous T Cell LymphomaPeripheral T Cell Lymphoma

Interventions

DRUG

Romidepsin

Trial Locations (13)

North Shore University Hospital, Manhasset

University of Pittsburgh, Pittsburgh

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

West Virginia University, Morgantown

Northwestern University, Chicago

University of Arkansas, Little Rock

Mayo Clinic Scottsdale, Scottsdale

City of Hope National Cancer Center, Duarte

Mercy General Hospital, Sacramento

Georgetown University, Washington D.C.

Royal Adelaide Hospital, Adelaide

Peter MacCallum Cancer Centre, Melbourne

Sir Charles Gairdner Hospital, Perth

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH